semaglutide 2.4 mg weekly Two-year effects of in adults with overweight or obesity: the STEP 5 trial semaglutide 2.4 mg weekly step

Pair this with formulas from our GHK-CU and AHK-CU peptide collection for a complete copper-peptide routine

Both medications work best alongside dietary changes and regular activity

In Phase 3 clinical trials completed in December 2025, retatrutide produced an average body weight reduction of 28.7% at the highest dose over 68 weeks

On tirzepatide, eating without hunger often triggers discomfort

Despite scientific backing, some consumers remain skeptical about the efficacy of glutathione-based products, especially in regions with limited awareness or cultural resistance to supplements and skincare ingredients

Novo Nordisk assigns a two-year ( 24-month) expiration date to Ozempic and Wegovy